STAP Stem Cell Controversy Ends in Suicide for Japanese Scientist
By Karen Kaplan,
Los Angeles Times
| 08. 05. 2014
Untitled Document
A Japanese scientist who played an instrumental role in two discredited studies about a new type of stem cells hanged himself at his research institute in Kobe, according to media reports there.
Yoshiki Sasai, a deputy director of the RIKEN Center for Developmental Biology, left behind five apparent suicide notes, Japan Times reported Tuesday.
“I am overcome with grief at this terrible news,” RIKEN President Ryoji Noyori said in a statement released Tuesday. “The scientific world has lost a talented and dedicated researcher, who earned our deep respect for the advanced research he carried out over many years. I would like to express my deepest condolences to Dr. Sasai’s family and colleagues.”
Sasai was a coauthor on two papers published in Nature that purported to offer a quick and simple way of making highly versatile stem cells. Instead of destroying embryos or tinkering with their DNA, the scientists said they produced their flexible cells by stressing them out in an acid bath for 30 minutes and then spinning them in a centrifuge for 5 minutes.
At first, scientists...
Related Articles
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
By Adam Zewe, MIT News | 02.07.2024
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.
In cell therapy, clinicians...
